Chemoinformaics analysis of 1,4-Dihydroxy-2-ethoxymethylanthraquinone
| Molecular Weight | 298.294 | nRot | 3 |
| Heavy Atom Molecular Weight | 284.182 | nRig | 19 |
| Exact Molecular Weight | 298.084 | nRing | 3 |
| Solubility: LogS | -3.715 | nHRing | 0 |
| Solubility: LogP | 3.589 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 12 |
| nHA | 5 | APOL | 41.7351 |
| nHD | 2 | BPOL | 17.5169 |
| QED | 0.506 |
| Synth | 2.88 |
| Natural Product Likeliness | 0.833 |
| NR-PPAR-gamma | 0.824 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.027 |
| Pgp-sub | 0 |
| HIA | 0.009 |
| CACO-2 | -4.704 |
| MDCK | 0.0000195 |
| BBB | 0.035 |
| PPB | 0.964296 |
| VDSS | 1.213 |
| FU | 0.035961 |
| CYP1A2-inh | 0.971 |
| CYP1A2-sub | 0.143 |
| CYP2c19-inh | 0.459 |
| CYP2c19-sub | 0.088 |
| CYP2c9-inh | 0.826 |
| CYP2c9-sub | 0.501 |
| CYP2d6-inh | 0.632 |
| CYP2d6-sub | 0.232 |
| CYP3a4-inh | 0.544 |
| CYP3a4-sub | 0.161 |
| CL | 5.075 |
| T12 | 0.301 |
| hERG | 0.017 |
| Ames | 0.959 |
| ROA | 0.145 |
| SkinSen | 0.622 |
| Carcinogencity | 0.911 |
| EI | 0.788 |
| Respiratory | 0.812 |
| NR-Aromatase | 0.027 |
| Antiviral | Yes |
| Prediction | 0.814076 |